Cargando…
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
SIMPLE SUMMARY: L-asparaginase (L-ASNase) therapy is key for achieving the very high cure rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this indication. One main reason preventing the expansion of today’s FDA-approved L-ASNases to solid cancers is their high...
Autores principales: | Van Trimpont, Maaike, Peeters, Evelien, De Visser, Yanti, Schalk, Amanda M., Mondelaers, Veerle, De Moerloose, Barbara, Lavie, Arnon, Lammens, Tim, Goossens, Steven, Van Vlierberghe, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870365/ https://www.ncbi.nlm.nih.gov/pubmed/35205650 http://dx.doi.org/10.3390/cancers14040902 |
Ejemplares similares
-
P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
por: Van Trimpont, Maaike, et al.
Publicado: (2023) -
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
por: Van Trimpont, Maaike, et al.
Publicado: (2022) -
Structural and Kinetic Characterization of Guinea
Pig l-Asparaginase
Type III
por: Schalk, Amanda M., et al.
Publicado: (2014) -
Discovery of human-like L-asparaginases with potential clinical use by directed evolution
por: Rigouin, Coraline, et al.
Publicado: (2017) -
Structural Insight into Substrate Selectivity of Erwinia chrysanthemil-Asparaginase
por: Nguyen, Hien Anh, et al.
Publicado: (2016)